Apo-Bicalutamide · DIN 02296063 · 50 mg · tablet
General benefitDormant since May 14, 2023 · checked November 18, 2026 · What does dormant mean?
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Apo-Bicalutamide · DIN 02296063
Manufacturer: Apotex Inc.; listing date 2008-01-15
Health Canada: Dormant since 2023-05-14 · brand APO-BICALUTAMIDE · ATC L02BB03 BICALUTAMIDE · form Tablet · route Oral · ingredients BICALUTAMIDE 50 MG · company Apotex inc · schedule Prescription
Apo-Bicalutamide: Formulary list price $1.27 per unit (the source does not state the unit; exact figure $1.2690). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02296063)
Source record
DIN 02296063: Apo-Bicalutamide
Raw flags: sec3=Y
Item: 100000108; group id 145; item number 0244; lccId None; manufacturer id APX
Source form: Tab; strength: 50mg
Recorded listing: General benefit
Source prices (unrounded): $1.2690; ministry $1.2690
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02296063
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=78142
Interchangeable products
Bicalutamide · DIN 02519178 · $1.2690
Bicalutamide Tablets · DIN 02325985 · $1.2690
Casodex · DIN 02184478 · not recorded
Co Bicalutamide · DIN 02274337 · $1.2690
Jamp-Bicalutamide · DIN 02357216 · $1.2690
PMS-Bicalutamide · DIN 02275589 · $1.2690
Ran-Bicalutamide · DIN 02371324 · $1.2690
Teva-Bicalutamide · DIN 02270226 · $1.2690
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Dormant since May 14, 2023 — choose a marketed DIN from the same-category list.